Tateishi T, Fujimura A, Shiga T, Ohashi K, Ebihara A
Department of Clinical Pharmacology and Therapeutics, Jichi Medical School, Tochigi, Japan.
Int J Clin Pharmacol Res. 1995;15(3):95-101.
The influence of aging on the hepatic metabolism of propranolol, i.e. conjugation, side-chain oxidation and ring oxidation, was investigated in 32 in-patients aged 30 to 84 yrs. Plasma propranolol concentration and main urinary metabolites [propranolol glucuronide (PPLG), naphthoxylactic acid (NLA), and 4-hydroxypropranolol (40HP)] were determined after a single oral dose of 20 mg propranolol. There were significant correlations between age and 1) maximum propranolol concentration, 2) area under the plasma concentration-time curve, and 3) elimination half-life. The apparent oral clearance of propranolol was inversely correlated with age. Partial metabolic clearance (PMC) to 40HP (ring oxidation) and PMC to NLA (side-chain oxidation) were significantly correlated with age, while PMC to PPLG was not. These observations suggest that there are age-related reductions in two oxidizing capacities, while there is no significant influence of aging on the conjugating capacity. The age-related reduction in oral clearance of propranolol may be mainly caused by the decline in the capacity of two different oxidation pathways.
在32名年龄在30至84岁的住院患者中,研究了衰老对普萘洛尔肝脏代谢(即结合、侧链氧化和环氧化)的影响。单次口服20毫克普萘洛尔后,测定血浆普萘洛尔浓度和主要尿液代谢物[普萘洛尔葡萄糖醛酸苷(PPLG)、萘氧乳酸(NLA)和4-羟基普萘洛尔(40HP)]。年龄与以下各项之间存在显著相关性:1)普萘洛尔最大浓度;2)血浆浓度-时间曲线下面积;3)消除半衰期。普萘洛尔的表观口服清除率与年龄呈负相关。向40HP(环氧化)的部分代谢清除率(PMC)和向NLA(侧链氧化)的PMC与年龄显著相关,而向PPLG的PMC则不然。这些观察结果表明,两种氧化能力存在与年龄相关的降低,而衰老对结合能力没有显著影响。普萘洛尔口服清除率与年龄相关的降低可能主要是由两种不同氧化途径的能力下降引起的。